The protective effect could be recapitulated by intraperitoneal injections of P2X7 antagonist Brilliant Blue G. It was proposed that P2X7 participated to the development of type 1 diabetes by contributing to the recruitment of antigen presenting cells and lymphocytes to the pancreas and pancreatic lymph node15. This evidence concerns the gene P2RX7 and type 1 diabetes mellitus.